These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1349586)

  • 1. Immunogenetics of multiple sclerosis and optic neuritis: DNA polymorphism of HLA class II genes.
    Morling N; Sandberg-Wollheim M; Fugger L; Georgsen J; Hylding-Nielsen JJ; Madsen HO; Rieneck K; Ryder L; Svejgaard A
    Immunogenetics; 1992; 35(6):391-4. PubMed ID: 1349586
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA typing in acute optic neuritis. Relation to multiple sclerosis and magnetic resonance imaging findings.
    Frederiksen JL; Madsen HO; Ryder LP; Larsson HB; Morling N; Svejgaard A
    Arch Neurol; 1997 Jan; 54(1):76-80. PubMed ID: 9006417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class II DR, DQ, and DP restriction fragment length polymorphisms in rheumatoid arthritis.
    Howell WM; Evans PR; Wilson PJ; Cawley MI; Smith JL
    Ann Rheum Dis; 1989 Apr; 48(4):295-301. PubMed ID: 2565707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HLA class II polymorphism using polymerase chain reaction.
    Erlich H; Bugawan T; Begovich A; Scharf S
    Arch Pathol Lab Med; 1993 May; 117(5):482-5. PubMed ID: 8489336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II alleles in juvenile dermatomyositis.
    Vavrincová P; Havelka S; Cerna M; Stastny P
    J Rheumatol Suppl; 1993 Apr; 37():17-8. PubMed ID: 8501745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosus.
    Reveille JD; Anderson KL; Schrohenloher RE; Acton RT; Barger BO
    J Rheumatol; 1991 Jan; 18(1):14-8. PubMed ID: 1673720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis identifies class II mismatches in serologically DR-compatible human renal allografts.
    Bushell A; Wood KJ; Morris PJ
    Hum Immunol; 1988 Nov; 23(3):191-206. PubMed ID: 2906639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up.
    Francis DA; Compston DA; Batchelor JR; McDonald WI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):758-65. PubMed ID: 3497228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymorphism of HLA class I and class II regions.
    Cohen D; Paul P; Le Gall I; Marcadet A; Font MP; Cohen-Haguenauer O; Sayagh B; Cann H; Lalouel JM; Dausset J
    Immunol Rev; 1985 Jul; 85():87-105. PubMed ID: 2412950
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
    J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction fragment length polymorphism (RFLP) heterogeneity of HLA-DQ beta genes associated with DNA fragment identical to the DR1-beta DNA structure.
    Redford A; Magalong D; Onohara-Toyoda M; Tyan D; Riley WJ; Maclaren NK; Rotter JI; Toyoda H
    Dis Markers; 1991; 9(5):257-63. PubMed ID: 1686750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis.
    Broomé U; Glaumann H; Hultcrantz R; Forsum U
    Scand J Gastroenterol; 1990 Jan; 25(1):54-8. PubMed ID: 2406888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: determination of a non-DR non-DQ gene product.
    Ababou A; Goyeneche J; Davis WC; Lévy D
    J Leukoc Biol; 1994 Aug; 56(2):182-6. PubMed ID: 7520928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA polymorphism of HLA class II genes in systemic lupus erythematosus.
    Cowland JB; Andersen V; Halberg P; Morling N
    Tissue Antigens; 1994 Jan; 43(1):34-7. PubMed ID: 7912858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of MHC class II antigen expression (HLA-DR, DP, and DQ) on peripheral blood T lymphocytes in patients after liver transplant.
    Winkler M; Schwinzer R; Wonigeit K
    Transplant Proc; 1989 Aug; 21(4):3627-8. PubMed ID: 2669267
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II major histocompatibility complex antigen expression on unstimulated and gamma-interferon stimulated monocytes from patients with multiple sclerosis, rheumatoid arthritis and normal controls.
    Armstrong MA; Crockard AD; Hawkins SA; Gamble LA; Shah S; Bell AL
    Autoimmunity; 1991; 9(3):261-8. PubMed ID: 1777559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II RFLP-typing in tinea imbricata patients from Papua New Guinea.
    Jazwinska EC; Bhatia K; Jenkins C; Serjeantson SW
    Tissue Antigens; 1990 Feb; 35(2):99-100. PubMed ID: 1971464
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations in HLA-DP and HLA-DQ antigen frequency in patients with dermatitis herpetiformis.
    Hall RP; Sanders ME; Duquesnoy RJ; Katz SI; Shaw S
    J Invest Dermatol; 1989 Oct; 93(4):501-5. PubMed ID: 2570807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DP antigen and Takayasu arteritis.
    Dong RP; Kimura A; Numano F; Yajima M; Hashimoto Y; Kishi Y; Nishimura Y; Sasazuki T
    Tissue Antigens; 1992 Mar; 39(3):106-10. PubMed ID: 1350869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.